Search - tctmd.com

Displaying 61 - 80 of 509

Sort: Relevancy | Date

News Conference News TCT 2021

De-escalating Prasugrel Reduces Net Events in Complex PCI for ACS

Yael L. Maxwell

October 22, 2021

News Conference News TCT 2021

EXAMINATION Confirms Poor 10-Year Prognosis in Diabetic Patients Post-STEMI

Michael O'Riordan

October 15, 2021

News Conference News TCT 2021

Crushed Prasugrel Loading Dose Still No Benefit at 1 Year in COMPARE CRUSH

Yael L. Maxwell

October 15, 2021

News Conference News TCT 2021

No Harm From Thrombolytics in SCAD Patients With STEMI

Michael O'Riordan

October 13, 2021

News Daily News

Women Stand to Gain the Most From Standardized STEMI Protocols

Michael O'Riordan

September 30, 2021

News Daily News

Coronary Revascularization Benefits Even Latecomer STEMI: FAST-MI Registry

Michael O'Riordan

September 21, 2021

News Conference News ESC 2021

IAMI: Influenza Vaccine Beneficial for Post-MI Patients

Michael O'Riordan

August 30, 2021

News Daily News ESC 2021

Colchicine in STEMI Fails to Reduce Infarct Size: COVERT-MI

Caitlin E. Cox

August 26, 2021

News Daily News

Colchicine Lowers CVD Risk No Matter When Past ACS Occurred: LoDoCo2

Michael O'Riordan

August 26, 2021

News

Tastes Like Ticagrelor: Mouth-Dissolving Pills Match Standard Ones in ACS

Yael L. Maxwell

July 13, 2021

News Daily News

Studies Explore Post-MI Use of Beta-blockers, Mineralocorticoid Receptor Antagonists

Todd Neale

July 09, 2021

News Daily News

Big Downturn in CVD Procedures Seen During COVID-19’s First Wave

Michael O'Riordan

July 01, 2021

Crushing Prasugrel Tabs Ups Platelet Inhibition Following Primary PCI

News Daily News

Crushed Prasugrel in the Ambulance Ups Platelet Inhibition in Primary PCI

Yael L. Maxwell

June 22, 2021

News Conference News EAS 2021

High Ischemic Risk and Bleeding Risk: A Delicate Balance Post-PCI

Michael O'Riordan

June 08, 2021

News Conference News EAS 2021

For High-Risk Patients Getting Evolocumab in Europe, Other Meds Fall Short

Michael O'Riordan

June 03, 2021

News Conference News ACC 2021

Extended TAILOR-PCI Data Again Show No Gains for Genotype-Guided Meds

Yael L. Maxwell

May 26, 2021

News Conference News ACC 2021

Global STEMI Initiative Helps Low- and Middle-Income Countries Achieve Better Metrics

L.A. McKeown

May 24, 2021

News Conference News EuroPCR 2021

Subcutaneous GP IIb/IIIa Inhibitor in STEMI Is Fast, Potent in Early Study

Todd Neale

May 18, 2021

News Conference News ACC 2021

Complete Revascularization Analysis of ISCHEMIA Opens ‘Pandora’s Box’

Michael O'Riordan

May 18, 2021

News Conference News ACC 2021

TALOS-AMI Supports Clopidogrel De-escalation After Earlier Ticagrelor Post-PCI

Yael L. Maxwell

May 17, 2021

Advertisement

De-escalating Prasugrel Reduces Net Events in Complex PCI for ACS

EXAMINATION Confirms Poor 10-Year Prognosis in Diabetic Patients Post-STEMI

Crushed Prasugrel Loading Dose Still No Benefit at 1 Year in COMPARE CRUSH

No Harm From Thrombolytics in SCAD Patients With STEMI

Women Stand to Gain the Most From Standardized STEMI Protocols

Coronary Revascularization Benefits Even Latecomer STEMI: FAST-MI Registry

IAMI: Influenza Vaccine Beneficial for Post-MI Patients

Colchicine in STEMI Fails to Reduce Infarct Size: COVERT-MI

Colchicine Lowers CVD Risk No Matter When Past ACS Occurred: LoDoCo2

Tastes Like Ticagrelor: Mouth-Dissolving Pills Match Standard Ones in ACS

Studies Explore Post-MI Use of Beta-blockers, Mineralocorticoid Receptor Antagonists

Big Downturn in CVD Procedures Seen During COVID-19’s First Wave

Crushed Prasugrel in the Ambulance Ups Platelet Inhibition in Primary PCI

High Ischemic Risk and Bleeding Risk: A Delicate Balance Post-PCI

For High-Risk Patients Getting Evolocumab in Europe, Other Meds Fall Short

Extended TAILOR-PCI Data Again Show No Gains for Genotype-Guided Meds

Global STEMI Initiative Helps Low- and Middle-Income Countries Achieve Better Metrics

Subcutaneous GP IIb/IIIa Inhibitor in STEMI Is Fast, Potent in Early Study

Complete Revascularization Analysis of ISCHEMIA Opens ‘Pandora’s Box’

TALOS-AMI Supports Clopidogrel De-escalation After Earlier Ticagrelor Post-PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content